Repositorio Dspace

Listar por tema "B7-H1 Antigen"

Listar por tema "B7-H1 Antigen"

Ordenar por:Orden:Resultados:

  • Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin 
    Capdevila, Jaume; Hernando, J; Teule, A; López, C; García-Carbonero, R; Benavent, M; Custodio, Ana-Belén; García-Álvarez, A; Cubillo, A; Alonso, V; Carmona-Bayonas, Alberto; Alonso-Gordoa, Teresa; Crespo, G; Jiménez-Fonseca, Paula; Blanco, M; Viudez, A; La-Casta, Adelaida; Sevilla, I; Segura, A; Llanos, M; Landolfi, S; Nuciforo, P; Manzano, José-Luis (NATURE PORTFOLIO, 2023-05)
    Single immune checkpoint blockade in advanced neuroendocrine neoplasms (NENs) shows limited efficacy; dual checkpoint blockade may improve treatment activity. Dune (NCT03095274) is a non-randomized controlled multicohort ...
  • Pembrolizumab in combination with gemcitabine for patients with HER2-negative advanced breast cancer: GEICAM/2015-04 (PANGEA-Breast) study 
    de-la-Cruz-Merino, L; Gion, M; Cruz, J; Alonso-Romero, JL; Quiroga, V; Moreno, F; Andres, R; Santisteban, M; Ramos, M; Holgado, E; Cortes, J; López-Miranda, E; Cortes, A; Henao, F; Palazon-Carrión, N; Rodríguez, LM; Ceballos, I; Soto, A; Puertes, A; Casas, M; Benito, S; Chiesa, M; Bezares, S; Caballero, R; Jiménez-Cortegana, C; Sánchez-Margalet, V; Rojo, F (BMC, 2022-12-03)
    BACKGROUND: We evaluated a new chemoimmunotherapy combination based on the anti-PD1 monoclonal antibody pembrolizumab and the pyrimidine antimetabolite gemcitabine in HER2- advanced breast cancer (ABC) patients previously ...